Palantir Technologies Inc. Total Cost of Revenue decreased by 0.1% to $215.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.8%, from $172.97M to $215.80M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 23.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $90.93M | $86.80M | $87.56M | $94.40M | $102.22M | $107.61M | $104.31M | $107.65M | $106.90M | $107.92M | $108.64M | $116.26M | $128.56M | $146.64M | $174.53M | $172.97M | $192.93M | $207.31M | $215.97M | $215.80M |
| QoQ Change | — | -4.5% | +0.9% | +7.8% | +8.3% | +5.3% | -3.1% | +3.2% | -0.7% | +1.0% | +0.7% | +7.0% | +10.6% | +14.1% | +19.0% | -0.9% | +11.5% | +7.4% | +4.2% | -0.1% |
| YoY Change | — | — | — | — | +12.4% | +24.0% | +19.1% | +14.0% | +4.6% | +0.3% | +4.1% | +8.0% | +20.3% | +35.9% | +60.7% | +48.8% | +50.1% | +41.4% | +23.7% | +24.8% |